Skip to main content
Caplight Logo









Patient Sortal

Patient Sortal

Private
Newark, DelawareHealthcare & Life Scienceshttps://www.patientsortal.com/

Last Round

Seed

Sep 5, 2023

Total Funding Raised

$1.46M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Patient Sortal is a healthcare technology and services company that provides data-driven care management, population health solutions, and primary care services for justice-involved individuals during community reintegration.

Sector

Healthcare & Life Sciences

Verticals

EHR & EMR, Healthcare Analytics, Patient Engagement

Business Model

B2B2C

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

population health managementcare coordinationcorrectional healthcarereentry healthcarejustice-involved healthreturning citizensclinical serviceshealthcare data managementvirtual primary caretelehealthsocial determinants of healthSDOHMedicaid managed carecontinuity of carehealth equity

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Patient Sortal Comparables

Compare Patient Sortal with similar companies based on industry and business-model similarity.

Patient Sortal comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Total Reentry Solutions
76%
Wellpath
66%
Q2i
64%

Patient Sortal Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 5, 2023
Growth EquityMay 1, 2023
SeedFeb 7, 2022
AcceleratorAug 18, 2021

Patient Sortal Investors

Notable investors and investment history

Patient Sortal investors
InvestorRounds
gener8torSeed
PraxisSeed
Sputnik ATXSeed, Accelerator
Impact FoundationSeed
Eagle Venture FundSeed
DealBenchGrowth Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 19, 2026

    Monthly visitors increased 181% MoM.

  • Jun 2, 2025

    Added Health Partners Plans, Inc. as a customer.

Patient Sortal Filings

Explore SEC and related filing metadata, where available.

Patient Sortal filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Patient Sortal's valuation, stock price, and market status.

Is Patient Sortal a public or private company?

Patient Sortal is a private company.

What is the current stock price of Patient Sortal?

Patient Sortal is a private company with no public stock price. No recent secondary market data is available.

How much is Patient Sortal worth (valuation)?

Valuation information for Patient Sortal is not publicly available.

Can I buy Patient Sortal stock?

Patient Sortal shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Patient Sortal's last funding round?

Patient Sortal's most recent funding round was Growth Equity on May 1, 2023.

Who are the main investors in Patient Sortal?

Key investors in Patient Sortal include DealBench.

Will Patient Sortal IPO soon?

No public IPO plans have been announced for Patient Sortal.

How can I track Patient Sortal secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Patient Sortal's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNewark, Delaware
Employee Range6
Year Founded2017
Last FundingSep 5, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?